Abstract: A system for mitigating violence in a clinical care environment. The system detects at least one individual who is exhibiting violent behavior. The system identifies a location of the at least one individual who is exhibiting the violent behavior based on data received from a location tracking system. The system controls operation of a first device based on the location of the at least one individual who is exhibiting the violent behavior, The system generates an alert based on the location of the at least one individual who is exhibiting the violent behavior, the alert communicated to a second device associated with a caregiver in the clinical care environment.

Abstract: Disclosed herein are organic photosensitive optoelectronic devices comprising acceptor and/or donor sensitizers to increase absorption and photoresponse of the photoactive layers of the devices. In particular, devices herein include at least one acceptor layer and at least one donor layer, wherein the acceptor layer may comprise a mixture of an acceptor material and at least one sensitizer, and the donor layer may comprise a mixture of a donor material and at least one sensitizer. Methods of fabricating the organic photosensitive optoelectronic devices are also disclosed.

Abstract: Described herein are super absorbent materials (SAMs) and methods of making SAMs. The SAMs are copolymerized after formation of monomer complexes to incorporate select inorganic salts into the polymerized SAMS. The SAMs are copolymerized with select stable inorganic salts and/or with select redox active inorganic salts. The SAMS are copolymerized in a single-step polymerization process or in a staged polymerization process. The copolymer-based SAMs have significantly improved absorbance properties. The compositions and methods described herein are useful in a variety of absorbent products.

Abstract: An apparatus includes a printing head (154) comprising jet nozzles (158) spaced apart from one another, where a distance from a first jet nozzle to a second jet nozzle positioned adjacent the first jet nozzle defines a jet-spacing, a printing head position control assembly includes a first actuator assembly (102) to move the printing head along the longitudinal axis and a second actuator assembly (103) to move the printing head along a latitudinal axis, and an control unit communicatively coupled to the printing head position control assembly. The control unit causes jet nozzles to dispense drops of binder (50) while the printing head traverses a first pass trajectory along the longitudinal axis in a first direction, indexes the printing head to a second pass trajectory along the latitudinal axis, and causes jet nozzles to dispense drops of binder while the printing head traverses the second pass trajectory along the longitudinal axis in a second direction.

Abstract: A novel catheter is disclosed comprising an electrode array that is capable of switching between a sensing configuration for sensing electrical signals of biological tissue and an ablation configuration for delivery of ablation energy at a region of interest. Irrigation ports are interlaced within the electrode array to vent irrigant during an ablation procedure to; prevent excessive heating, charring of tissue, coagulation of blood, and allow for efficient delivery of ablation therapy for maximum therapy efficacy. The novel catheter includes a plurality of splines with linear portions wherein the electrodes of the electrode array are disposed. The splines are connected by connectors which include one or more bends capable of storing potential energy when the bends are elastically deformed, enabling collapse and expansion of the catheter in a sheath.

Abstract: Devices for treating a cerebral aneurysm may include proximal and distal self-expanding resilient permeable shells each including a plurality of elongate resilient filaments having a braided structure. The distal permeable shell may include a first plurality of filaments gathered at least at the proximal end thereof. The proximal permeable shell may include a second plurality of filaments are gathered at least at the proximal end thereof. The expanded state of the distal permeable shell may have a convex shape at the distal end of the distal permeable shell and the expanded state of the proximal permeable shell may have a generally convex shape at the proximal end of the proximal permeable shell. The expanded states of the distal and proximal permeable shells may also define a toroidal cavity through which an elongate support member extends.

Abstract: Provided are compounds comprising at least one monoanionic bidentate ligand LA represented by Formula I or a tautomer thereof. Also provided are formulations comprising compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: The present disclosure provides amide M carbene emitters of Formula (I); organic light emitting device (OLED) comprising an anode, a cathode, and an organic layer, disposed between the anode and the cathode, comprising a compound of Formula (I); and consumer products comprising an OLED comprising a compound of Formula (I):

Abstract: Implantable medical electrical leads having electrodes arranged such that a defibrillation coil electrode and a pace/sense electrode(s) are concurrently positioned substantially over the ventricle when implanted as described. The leads include an elongated lead body having a distal portion and a proximal end, a connector at the proximal end of the lead body, a defibrillation electrode located along the distal portion of the lead body, wherein the defibrillation electrode includes a first electrode segment and a second electrode segment proximal to the first electrode segment by a distance. The leads may include at least one pace/sense electrode, which in some instances, is located between the first defibrillation electrode segment and the second defibrillation electrode segment.

Abstract: The application includes systems and methods for phenotyping. A request is received to identify a target population having a phenotype. Predefined characteristics associated with the phenotype are obtained. Using a retriever model, a set of subjects is identified as potential members of the target population by searching databases. Medical information is obtained by searching a second set of one or more databases and providing corresponding information to an artificial intelligence (AI) component. Natural language instructions are provided to the AI component to provide context to the AI component to determine whether a respective subject in the set of subjects has at least one of the one or more predefined characteristics. A subset of subjects is identified by the AI system to be, or to have a high likelihood of being, a member of the target population.

Abstract: An apparatus for controlling the printing on wire or cable. The apparatus including a processor, a bus connected to the processor, a user input connected to the bus, a display screen connected to the user input and the bus, a first storage system connected to the bus, data stored in the first storage system and displayable on the display screen, wherein the data includes manufacturing and print information, a printer connected to the bus, wherein the printer prints the data on the wire or cable, a communication device connected to the bus, and an identification device connected to the bus, wherein identification device receives information from a user.

Abstract: In some examples, a medical device includes an elongated structure configured to extend from an access point of a patient through an intercostal space within the patient. The medical device may further include a plurality of electrodes comprising a first subset of electrodes and a second subset of electrodes, where at least the first subset of electrodes is carried on a distal portion of the elongated structure. The first subset of electrodes of the plurality of electrodes may be configured to deliver electrical therapy to a heart of the patient or sense cardiac activity. The second subset of electrodes of the plurality of electrodes may be configured to deliver energy to tissue proximate a ribcage of the patient to reduce a sensation in one or more intercostal nerves.

Abstract: This disclosure describes implantable medical leads and medical device systems utilizing the leads. In some examples, an implantable medical lead comprises a first defibrillation electrode and a second defibrillation electrode, the first and second defibrillation electrodes configured to deliver anti-tachyarrhythmia shocks, and a pace electrode disposed between the first defibrillation electrode and the second defibrillation electrode, the pace electrode configured to deliver a pacing pulse that generates an electric field proximate to the pace electrode. The implantable medical lead further comprises a shield disposed between the first defibrillation electrode and the second defibrillation electrode and over a portion of an outer surface of the pace electrode, wherein the shield is configured to impede the electric field in a direction from the pace electrode away from a heart.

Abstract: Provided are compounds comprising at least one ligand LA, represented by Formula I wherein at least one of RA and RB comprises a substituent capable of thermally activated delayed fluorescence, a ?-deficient heterocycle, or a trisubstituted boron atom. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: Methods of forming a fertilizer composition having slow-release nitrogen compounds with a molten process are disclosed. The methods include mixing of a crystalline polyethylene wax with urea and formaldehyde to form a molten methylene urea mixture. The contents of the molten methylene urea mixture react to form slow-release nitrogen compounds. Fertilizer compositions formed of or including the slow-release nitrogen compounds are also disclosed.

Abstract: A compound selected from the group consisting of Formula I, Formula II, and Formula III, wherein ring A, ring B, and ring C are independently a five-membered or six-membered, carbocyclic or heterocyclic ring, each of which is optionally aromatic; ring W of Formula I is a 6-membered heterocyclic ring, and ring W of Formula II or Formula III is a 5-membered or 6-membered heterocyclic ring; L is a monodentate ligand with a metal coordinating member selected from the group consisting of C, N, O, S, and P; and M is a metal selected from the group consisting of Cu, Au, and Ag.

Abstract: Extravascular implant tools that utilize a bore-in mechanism to safely access extravascular locations and implant techniques utilizing these tools are described. The bore-in mechanism may include a handle and a helix extending from the handle. The bore-in mechanism is used, for example, in conjunction with a tunneling tool to traverse the diaphragmatic attachments to access a substernal location. The tunneling tool may be an open channel tunneling tool or a conventional tunneling tool (e.g., metal rod).

Abstract: Provided are compounds of Formula I wherein at least one of RA, RB, RC, and RD represents a group of Formula A. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: An implantable cardioverter defibrillator (ICD) receives a cardiac electrical signal by a sensing circuit while operating in a sensing without pacing mode and detects asystole based on the cardiac electrical signal. The ICD determines, in response to detecting the asystole, if asystole backup pacing is enabled, and automatically switches to a temporary pacing mode in response to the asystole backup pacing being enabled. Other examples of detecting asystole and providing a response to detecting asystole by the ICD are described herein.

Abstract: A medical device is configured to deliver therapeutic electrical stimulation pulses by generating frequency modulated electrical stimulation pulse signals. The medical device includes a pulse signal source and a modulator. The pulse signal source generates an electrical stimulation pulse signal having a pulse width. The modulator may include a high frequency modulator configured to modulate a frequency of the pulse signal from a starting frequency down to a minimum frequency during the pulse width. The modulator may include a low frequency bias generator to modulate the offset of the pulse signal between a minimum offset and a maximum offset in other examples.